Balance Sheet
Accounts PayablesAssetsCash & EquivalentsCommon EquityConvertible DebtCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Non-Current AssetsPayablesPensionProperty, Plant & Equipment (Net)Retained EarningsShort term DebtTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Abivax (ABVX) Convertible Debt (2023 - 2025)

Historic Convertible Debt for Abivax (ABVX) over the last 3 years, with Q3 2025 value amounting to $143.4 million.

  • Abivax's Convertible Debt changed N/A to $143.4 million in Q3 2025 from the same period last year, while for Sep 2025 it was $143.4 million, marking a year-over-year change of. This contributed to the annual value of $121.8 million for FY2024, which is 4617.56% up from last year.
  • According to the latest figures from Q3 2025, Abivax's Convertible Debt is $143.4 million.
  • Abivax's Convertible Debt's 5-year high stood at $143.4 million during Q3 2025, with a 5-year trough of $82.9 million in Q4 2023.
  • Moreover, its 3-year median value for Convertible Debt was $119.7 million (2024), whereas its average is $118.6 million.
  • Its Convertible Debt has fluctuated over the past 5 years, first surged by 4696.06% in 2024, then tumbled by 869.53% in 2025.
  • Over the past 3 years, Abivax's Convertible Debt (Quarter) stood at $82.9 million in 2023, then skyrocketed by 46.96% to $121.8 million in 2024, then increased by 17.73% to $143.4 million in 2025.
  • Its Convertible Debt was $143.4 million in Q3 2025, compared to $117.6 million in Q2 2025 and $117.2 million in Q1 2025.